alpha-aminopyridine has been researched along with Cells, Neoplasm Circulating in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrera Loeza, SG; Kamande, JW; Moffitt, RA; Soper, SA; Tignanelli, CJ; Torphy, RJ; Yeh, JJ | 1 |
| Ali, SM; Fernandez-Rocha, MY; Gitlitz, BJ; Lee, TK; Milliken, J; Ou, SI; Pavlick, D; Schrock, AB; Young, L; Zhu, VW | 1 |
2 other study(ies) available for alpha-aminopyridine and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aminopyridines; Animals; Antigens, Neoplasm; Biomarkers; Cell Adhesion Molecules; DNA Mutational Analysis; DNA Primers; Epithelial Cell Adhesion Molecule; Fluorescent Antibody Technique; Humans; Mice; Microfluidic Analytical Techniques; Morpholines; Neoplastic Cells, Circulating; Pancreatic Neoplasms; Statistics, Nonparametric | 2014 |
Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Topics: Adult; Aged; Aminopyridines; Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplastic; Crizotinib; Disease Progression; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Lactams; Lactams, Macrocyclic; Liquid Biopsy; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplastic Cells, Circulating; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Retinoblastoma Binding Proteins; Small Cell Lung Carcinoma; Ubiquitin-Protein Ligases | 2017 |